# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125613
Filing Date
2024-11-12
Accepted
2024-11-12 17:00:09
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rkda-20240930.htm iXBRL | 10-Q | 2594853
2 | EX-31.1 | rkda-ex31_1.htm | EX-31.1 | 13114
3 | EX-31.2 | rkda-ex31_2.htm | EX-31.2 | 13165
4 | EX-32.1 | rkda-ex32_1.htm | EX-32.1 | 8020
5 | EX-32.2 | rkda-ex32_2.htm | EX-32.2 | 7977
| Complete submission text file | 0000950170-24-125613.txt |  | 12234622

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rkda-20240930.xsd | EX-101.SCH | 1797895
78 | EXTRACTED XBRL INSTANCE DOCUMENT | rkda-20240930_htm.xml | XML | 2642705

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37383 | Film No.: 241449567
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)